Inflammatory signaling pathways, such as nuclear factor kappa B (NF-κB) or its downstream mediators, such as tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6) or interleukin-1 beta (IL-1β), are dysregulated in DMD models [4,5]. This evidence concerns the gene IL1B and Duchenne muscular dystrophy.